J&J's Revenue Falls on Currency Woes

Health-care giant Johnson & Johnson reported a 2.4% drop in December quarter sales as adverse foreign exchange rates offset strong growth in U.S. pharmaceutical sales.

from WSJ.com: US Business http://ift.tt/20quppz
via IFTTT